The frenetic M&A activity in healthcare is rather disorienting and difficult to keep up with. We’ve rounded up the key themes we are seeing and what this may mean for all of us.
2018 was quite the year for M&A activity in healthcare. Some big announcements made waves such as the Amazon-PillPack, Roche-Flatiron, Cigna-Express Scripts, CVS-Aetna, ResMed-Propeller deals, there were hundreds of smaller ones too. We dig into what the ResMed - Propeller deal could mean for all.
The new wave in the industry is Digital Therapeutics (DTx). The term came into existence under the premise that mobile software can be effective medical treatments. DTx certainly seem to exhibit a superiority above all the 'banal' digital health solutions, but is the promise real?
In this week’s blog we are doing a round-up of our Global Gathering in Mumbai, discussing the digital health landscape in India and some of our key learnings from the event.
The FDA and European commission have taken some big steps as a response to the burgeoning digital health market, while still trying to fulfill its mission of protecting public health. In this blog, we look at American and European initiatives in putting some structure on the regulation of SaMDs.
Recap of HealthXL's Global Gathering in Menlo Park, hosted by GE Ventures. Highlighting the opioid crisis, solutions and removing the stigma. Also shining a light on how technology can enhance seniors living with dementia, by designing tools that address their needs and ability.
Is Alexa the new voice of healthcare delivery? She can give information about the weather, the news, play music, tell jokes, etc, surely she can solve your health woes, right? Maybe not just yet. Alexa won’t change healthcare delivery until she is HIPAA compliant.
Digital innovations that are unleashing the power of technology to fundamentally change how patient care is delivered in India. These innovations span across a wide range of areas such as telemedicine, appointment management, e-pharmacies and adherence tracking.
Scott Weiner MD, Assistant Professor of Emergency Medicine at Brigham and Women's Hospital who has spent many years researching and advocating for solutions to curb the opioid epidemic explains why he became interested in the topic, how hospitals can more effectively deal with this crisis.
We outline the stories of two very different humans whose paths cross given their relationship as patient and physician. You can see the problem of addiction and the hardships in treatment (even if very evidence-based) through their eyes.
Medical education needs a bit of shaking up, and medical schools are beginning to innovate to prepare new physicians for the emerging new model of care.
Digital therapeutics is at an inflection point in its hype cycle progression and has quickly begun to demonstrate its true potential as a solidified new category in healthcare today.
GDPR is set to place a greater responsibility on companies to actively engage with the people whose data they are processing, the healthcare industry will be impacted by a new paradigm on how privacy, personal information and consent are managed.
The United States is in the midst of the worst drug crisis in the nation’s history, a toll measured in fatalities on a scale never seen before. With a record-setting 42,000+ drug overdose deaths involving an opioid in 2016.